Legal & General Group
CATX icon

Legal & General Group’s Perspective Therapeutics CATX Stock Holding History

Legal & General Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.2K Buy
10,029
+4,603
+85% +$17.4K ﹤0.01% 2905
2026
Q1 		$22.6K Hold
5,426
– – ﹤0.01% 2920
2025
Q4 		$14.9K Hold
5,426
– – ﹤0.01% 3132
2025
Q3 		$18.6K Hold
5,426
– – ﹤0.01% 3068
2025
Q2 		$18.7K Sell
5,426
-377
-6% -$995 ﹤0.01% 3037
2025
Q1 		$12.4K Sell
5,803
-42,735
-88% -$128K ﹤0.01% 3107
2024
Q4 		$155K Hold
48,538
– – ﹤0.01% 2688
2024
Q3 		$647K Buy
48,538
+12,163
+33% +$162K ﹤0.01% 2375
2024
Q2 		$363K Buy
+36,375
New +$526K ﹤0.01% 2537

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Legal & General Group's CATX Position: Q2 2026 in Review

Legal & General Group increased its Perspective Therapeutics (CATX) stake by 85% in Q2 2026, buying an estimated $17.4K and bringing the position to 10,029 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2905.

Legal & General Group first reported a position in CATX in Q2 2024 and has held it in 9 quarters since. The position peaked at $647K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Legal & General Group held 10,029 shares of Perspective Therapeutics worth $34.2K as of Q2 2026.
  • Legal & General Group bought 4,603 Perspective Therapeutics shares in Q2 2026, an estimated $17.4K.
  • Perspective Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2905 holding.
  • Legal & General Group first reported a position in Perspective Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Legal & General Group's Perspective Therapeutics position peaked at $647K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.